NCT02610504

Prospective Single Center Open Label Study of Shoulder OA Pain

A 26 Week Prospective Open Label Clinical Study Evaluating A Single Intra-Articular Injection of Durolane 3ml for Treatment of Osteoarthritis Pain of the Shoulder

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 41 (actual)
• Sponsor: Bioventus LLC · Industry
• Sex: All
• Age: 19 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Open label, prospective, single cohort study of Durolane 3ml intra-articular injection into the shoulder for pain in mild to moderate patients

Detailed description

Subjects 19-85 years old will receive a single intra-articular (IA) injection of DUROLANE® 3mL given for the relief of pain in the treatment of symptomatic osteoarthritis (OA) of the shoulder followed over a 26-week time period.

Conditions

• Osteoarthritis

Interventions

Type	Name	Description
DEVICE	Durolane	single injection of 3ml

Timeline

• Start date: 2015-04-08
• Primary completion: 2017-05-23
• Completion: 2017-05-23
• First posted: 2015-11-20
• Last updated: 2021-02-16

Locations

1 site across 1 country: Canada